Bone marrow transplantation is still the only potential option of a cure for hematological tumors Published on 23/02/2023 Bone marrow donation, which may improve the patient's prognosis, does not pose any health risk for the donor nor does it require admission to the operating room
MD Anderson Madrid – Hospiten participates in a protocol for bone marrow transplant patients to receive treatment at its center after the procedure Published on 25/02/2021 This allows patients with lymphoma or multiple myeloma who require a hematopoietic stem cell transplant to return to their center of origin to continue their own post-transplant care
MD Anderson Cancer Center Madrid – Hospiten launches a new Haematopoietic Transplant Unit Published on 27/02/2020 After more than 15 years of experience in autologous and allogeneic transplants, MD Anderson Cancer Madrid has launched a new Haematopoietic Transplant Unit with a view to enhancing and developing the transplant programme and offering CAR-T therapy.